scorecardresearchAarti Drugs Share Price Live NSE, BSE, Today - Aarti Drugs Stock Price

Aarti Drugs

BSE: 524348 | NSE: AARTIDRUGS | ISIN: INE767A01016 | SECTOR: Biotechnology & Drugs

494.90 0.60 (0.12%)

22 May 2024, 10:27 (IST)
  • Open

    490.10
  • High

    499.00
  • Low

    487.95
  • Prev Close

    494.30
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    45.50B
  • Volume

    16.01K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    -
  • Ask

    494.20

Company Description

  • Biotechnology & Drugs
  • BSE

    524348
  • NSE

    AARTIDRUGS
  • ISIN

    INE767A01016

Aarti Drugs Limited is an India-based company that is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include ciprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole and ofloxacin, among others. Its specialty chemicals products include benzene sulphonyl chloride and methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include itraconazole, fluconazole, dabigatran, ticagrelor, sitagliptin and alpha lipoic acid. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SPA.

Company Officers

  • Prakash Patil

    Chairman of the Board, Chief Executive Officer, Managing Director, Executive Director
  • Adhish Patil

    Chief Financial Officer, Chief Operating Officer
  • Rushikesh Deole

    Compliance Officer, Company Secretary
  • Harshit Savla

    Joint Managing Director, Executive Director
  • Rashesh Gogri

    Managing Director, Executive Director
  • Uday Patil

    Executive Director
  • Harit Pragji Shah

    Executive Director